Literature DB >> 11341513

Absence of fibrinogen in afibrinogenemia results in large but loosely packed thrombi under flow conditions.

J A Remijn1, Y P Wu, M J Ijsseldijk, J J Zwaginga, J J Sixma, P G de Groot.   

Abstract

We studied the role of fibrinogen in platelet thrombus formation under flow on adhesive proteins using afibrinogenemic blood (LMWH anticoagulated) in a perfusion system. Perfusions with afibrinogenemic blood showed strong increased surface coverage and thrombus volume that normalized upon addition of fibrinogen. Similar studies using citrate anticoagulated blood showed that this was due to fibrinogen and not fibrin. Morphological analysis showed that afibrinogenemic thrombi were loosely packed and consisted mainly of dendritic platelets that contacted one another through filopodia. However, in the presence of fibrinogen, platelets formed lamellipodia and spread out on top of one another. Studies with radiolabeled platelets showed similar numbers of platelets in both conditions demonstrating that the difference is one of packing and the larger size is due to absence of lamellipodia formation and spreading. The found increased thrombus size and loosely packed platelets might help to understand thrombotic complications sometimes seen in afibrinogenemia patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11341513

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication.

Authors:  Nevin Oruc; Yaman Tokat; Refik Killi; Murat Tombuloglu; Tankut Ilter
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

2.  Polyphosphate nanoparticles on the platelet surface trigger contact system activation.

Authors:  Johan J F Verhoef; Arjan D Barendrecht; Katrin F Nickel; Kim Dijkxhoorn; Ellinor Kenne; Linda Labberton; Owen J T McCarty; Raymond Schiffelers; Harry F Heijnen; Antoni P Hendrickx; Huub Schellekens; Marcel H Fens; Steven de Maat; Thomas Renné; Coen Maas
Journal:  Blood       Date:  2017-01-03       Impact factor: 22.113

Review 3.  Functional property of von Willebrand factor under flowing blood.

Authors:  Mitsuhiko Sugimoto; Shigeki Miyata
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

Review 4.  Mechanobiology of platelets: techniques to study the role of fluid flow and platelet retraction forces at the micro- and nano-scale.

Authors:  Shirin Feghhi; Nathan J Sniadecki
Journal:  Int J Mol Sci       Date:  2011-12-07       Impact factor: 5.923

Review 5.  Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.

Authors:  Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

6.  Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency.

Authors:  Claudia Djambas Khayat; Sunil Lohade; Fulton D'Souza; Latha Gowda Shamanur; Omid Reza Zekavat; Irina Kruzhkova; Bruce Schwartz; Cristina Solomon; Sigurd Knaub; Flora Peyvandi
Journal:  Haemophilia       Date:  2020-12-16       Impact factor: 4.287

Review 7.  Treatment of congenital fibrinogen deficiency: overview and recent findings.

Authors:  Konstantinos Tziomalos; Sofia Vakalopoulou; Vassilios Perifanis; Vassilia Garipidou
Journal:  Vasc Health Risk Manag       Date:  2009-10-12

Review 8.  Integrating platelet and coagulation activation in fibrin clot formation.

Authors:  Frauke Swieringa; Henri M H Spronk; Johan W M Heemskerk; Paola E J van der Meijden
Journal:  Res Pract Thromb Haemost       Date:  2018-05-20

9.  Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients.

Authors:  Toshko Lissitchkov; Bella Madan; Claudia Djambas Khayat; Nadezhda Zozulya; Cecil Ross; Mehran Karimi; Kaan Kavakli; Guillermo R De Angulo; Abdulkareem Almomen; Kannan Subramanian; Fulton D'Souza; Auro Viswabandya; Hamid Hoorfar; Bruce A Schwartz; Cristina Solomon; Sigurd Knaub; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-01-21       Impact factor: 5.824

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.